Careers  |  Sign In  |  Register  |   Twitter

Latest in Hematology-Oncology

According to results of a multicenter randomized clinical trial, patients with advanced NSCLC derived no benefit from the addition of sorafenib (Nexavar) to chemotherapy. References and Resources Scagliotti G et al. "Sorafenib plus carboplatin/paclitaxel in chemonaive patients with stage IIIB-IV...

Electronic brachytherapy

Advances in Partial Breast Radiation

Vivek K. Mehta, MD, Radiation Oncologist, Director, Center for Advanced Targeted Radiotherapies, Department of Radiation Oncology, Swedish Cancer Institute, Seattle, WA, discusses advances in partial breast radiation. References and Resources Holt RW, Rivard MJ. Electronic brachytherapy: comparisons...
At the 2008 Atlantic Regional Osteopathic Convention, Joseph Minniti, Founder and Director of The Cancer Foundation for Personal Appearance Inc., gives feedback on how The Doctor's Channel has impacted his foundation. The Cancer Foundation for Personal Appearance Sponsored by The Doctor's...